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Background: The early steps of human immunodefi-
ciency virus 1 (HIV-1) replication involve reverse tran-
scription of the viral RNA and integration of the resulting
cDNA into a host chromosome. The DNA integration
step requires the integration machinery ('preintegration
complex') to bind to the host DNA before connecting the
viral and host DNAs. Here, we present experiments that
distinguish among three possible pathways of target-DNA
capture: repeated binding and release of target DNA prior
to the chemical strand-transfer step; binding followed by
facilitated diffusion along target DNA (sliding); and inte-
gration at the initial target-capture site. The mechanism of
target-DNA capture has implications for the design of
gene therapy methods, and influences the interpretation
of results on the selection of integration target sites in vivo.
Results: We present new in vitro conditions that allow us
to assemble HIV-1 integrase - the virus-encoded recom-
bination enzyme - with a viral DNA and then to trap
assembled complexes bound to target DNA. We find that
complexes of integrase and viral DNA do not slide along
target DNA substantially after binding. We confirm and
extend these results by analyzing target capture by a
hybrid protein composed of HIV-1 integrase linked to a
sequence-specific DNA-binding domain. We find that
the integrase domain binds quickly and tightly under the
above conditions, thereby obstructing function of the
fused sequence-specific DNA-binding domain. We also
monitor target-DNA capture by HIV-1 preintegration
complexes purified from freshly infected cells. Partially
purified complexes commit quickly and stably to the first
target DNA added, whereas preintegration complexes in
crude cytoplasmic extracts do not. The addition of extracts
from uninfected cells to partially purified complexes
blocks quick commitment.
Conclusions: Under new conditions favorable for the
analysis of target-DNA capture in vitro, HIV-1 integrase
complexes bind quickly and stably to target DNA with-
out subsequent sliding. Parallel studies of preintegration
complexes support a model in which target-site capture in
vivo is reversible as a result of the action of cellular factors.
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Introduction
In order to replicate, a retrovirus must integrate a DNA
copy of its RNA genome into a chromosome of the host
[1]. How the retroviral integration system selects a partic-
ular integration-acceptor site from among the myriad
possible sites in vivo is unclear. Integration acceptor sites
have been reported to lie most frequently near DNAse I-
hypersensitive sites [2,3], consistent with the idea that
open chromatin regions are favored for integration.
However, a recent study has presented evidence that
many chromosomal regions serve as integration-acceptor
sites with about equal frequency [4]. Another possible
influence on target site selection is the potential binding
of the integration apparatus to host proteins bound to
cellular DNA. Such a tethering mechanism may explain
selective integration by the retrovirus-like yeast retro-
transposon Ty3, which integrates near the start site of
genes transcribed by RNA Polymerase III [5,6]. Yeast
Tyl also displays highly selective integration [7], mediated
by an unknown but possibly related mechanism.
We have demonstrated previously, in vitro, that a hybrid
protein composed of human immunodeficiency virus 1
(HIV-1) integrase fused to the DNA-binding domain of 
repressor could direct integration selectively to DNA
sequences near binding sites for repressor [8]. The finding
that this artificial means of tethering an integrase to tar-
get DNA suffices for selective integration is consistent
with the idea that tethering might mediate selective inte-
gration in naturally occurring systems. Furthermore, a
cellular protein that binds HIV-1 integrase has been iden-
tified and proposed to promote integration in vivo by
tethering integrase to target DNA [9].
Which, if any, of the above mechanisms is likely to influ-
ence the selection of the integration site in vivo will be
strictly determined by the nature of the association
between the target DNA and the integration complex.
Three possible association mechanisms are presented in
Figure 1. Firstly, the integrase-HIV-1 DNA complex
'might bind and release target DNA many times before
actually carrying out the chemical steps of integration
(Fig. la). Secondly, integrase might bind to target DNA
and slide along it for some distance prior to integration
(Fig. lb). Thirdly, integrase might bind irreversibly to
the first target DNA encountered and carry out integra-
tion at that site (Fig. c). For tethering to affect the
selection of an integration target site, some form of
target-DNA exploration must take place, by either of the
first two mechanisms.
Here, we investigate the mechanism of target-DNA
capture using integration reactions in vitro. We have
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Fig. 1. Candidate mechanisms for target DNA capture by HIV-1
integrase. An HIV-1 DNA end is represented by a thick ladder,
and target DNA by a thin ladder. (a) The integration complex
binds and releases target DNA many times before carrying out
the chemical step of integration. (b) The integration complex
binds to target DNA and slides along it prior to carrying out inte-
gration. (c) The integration complex binds to target DNA and
integrates at that site.
found new conditions that allow the target capture and
chemical steps of integration to be distinguished, and
used such reactions to investigate the mechanism of tar-
get-capture by complexes of integrase and model viral
cDNAs. We have also compared the mechanism of tar-
get capture using two other sources of integration activ-
ity: a fusion protein consisting of integrase and A
repressor, and viral nucleoprotein complexes (pre-
integration complexes) purified from infected cells.
We find that both of the pathways shown in Figure
la,c can operate under different conditions, and that
components of host cells may influence the pathway of
target-site capture.
Results
Strand transfer directed by purified HIV-1 integrase in the
presence of Mg2 + and DMSO
Experiments to distinguish target-DNA binding from the
chemical step of strand transfer were made possible by
the development of conditions in vitro in which target
binding is relatively fast compared with strand transfer.
For these reactions, an oligonucleotide matching one end
of the unintegrated viral cDNA (the long terminal repeat
or LTR) was used as an integration donor (labeled with
32p at the 5' end), and a circular plasmid DNA was used
as an integration target (Fig. 2a) [10-13]. Integration
results in the covalent attachment of the LTR oligonu-
cleotide to one strand of the target DNA, yielding a
'tagged circle' product. Integration products migrate in
gels with the mobility of the relaxed circular form of the
target plasmid, as integration introduces a nick in the
plasmid and the mass contributed by the integrated
oligonucleotide is small.
In the presence of Mn 2+, purified HIV-1 integrase is
capable of removing two nucleotides from the 3' end of
the viral cDNA [10,14-16]. In the presence of Mg2 +,
this activity was not prominent under our conditions
(data not shown). However, strand transfer took place
efficiently in the presence of Mg2 + using LTR oligonu-
cleotides that lacked the two nucleotides normally
removed by integrase. Reaction conditions employing
Fig. 2. Integration reactions in the pres-
ence of Mg2+. (a) The integration reac-
tion. DNAs are drawn as ladders; the
asterisk indicates a 32p label at the 5'
end of the LTR oligonucleotide. (b)
Time courses of integration reactions in
the presence or absence of DMSO or
RNase T1.
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Mg2+ instead of Mn2 + are of particular interest, as Mg2+
is more abundant in vivo and hence is likely to be the
metal used by integrase during retroviral infection.
Integrase and the LTR oligonudeotide were preincubated
at 37 C for 5 minutes, forming a stable complex as
described previously [17]. Target DNA was then added
and the incubation continued at 37 °C. for 30 minutes.
dimethyl sulfoxide (DMSO) stimulated strand transfer
substantially under these conditions, and the addition of a
small basic protein (RNAse T1) stimulated transfer slightly
further. The effect of a small basic protein was tested
because such proteins have been reported previously to
stimulate integration in an in vitro genetic assay [11]. The
reaction was largely complete after 10 minutes (Fig. 2b).
Rapid and stable capture of target DNA by purified integrase
To begin to investigate target DNA capture by integrase-
LTR complexes, integration reactions were carried out in
which two target DNAs were added sequentially, to ask
whether the first target added was preferred (Fig. 3). After
both targets were added, reaction mixtures were incu-
bated for- a further 30 minutes to allow integration prod-
ucts to accumulate. To distinguish integration into each
plasmid in mixtures, two plasmids of different sizes (plas-
mid A of 5.4 kb and plasmid B of 1.2 kb, see Materials
and methods)-were used.
The simultaneous addition of plasmids A and B yielded
radioactive signals with the mobility of the relaxed circu-
lar form of each plasmid, as expected for integration into
both target DNAs (Fig. 3a,b, lane 1). Two bands arise
from integration into plasmid B (labeled B and B')
because the small plasmid B requires a second larger plas-
mid (B') to support replication, and both plasmids are
present in the preparation. Addition of plasmid B only 20
seconds after plasmid A resulted in integration into plas-
mid A almost exclusively (Fig. 3a, compare lanes 1,2). A
similar preference was seen when plasmid B was added
one, two or six minutes after plasmid A. Adding plasmid
B before plasmid A (Fig. 3b) resulted in preferential inte-
gration into plasmid B, indicating that the order of addi-
tion and not the identity of the target determined the
target DNA selected.
As a control, it was necessary to show that the observed
preferential use -of the first target added was due to fast
commitment rather than fast integration. Reactions were
therefore carried out exactly as above, except that the
reactions were stopped at the time of addition of the sec-
ond target plasmid. After 20 seconds of incubation with
the first target DNA, no significant integration was seen
(Fig. 3a,b, lane 6). After 1 minute, integration product
was detectable and it was prominent by 6 minutes. Thus,
the strong bias for integration into the first target DNA
added cannot be explained by fast integration into that
target within the first 20 seconds. These data support a
model in which target capture under these conditions
proceeds by either fast irreversible binding (Fig. c) or
binding with subsequent sliding (Fig. lb).
Fig. 3. Stable commitment of integrase-LTR complexes to target
DNA. Reactions were carried out in the presence of 5 mM MgCI 2
and 20 % DMSO. (a) Addition of plasmid A followed by addition
of plasmid B at various times thereafter. (b) Addition of plasmid
B followed by addition of plasmid A at various times. Times
before addition of the second plasmid are indicated at the top of
the autoradiograms (lanes 1-5); times before stopping the reac-
tion are indicated above lanes 6-9. Reactions containing Mn2+
were too fast to be analyzed by this method (data not shown).
See text for details.
Lack of sliding on target DNA following target capture
To determine whether integrase-LTR complexes slide
along target DNA in the above conditions, integrase-LTR
complexes were prebound to a linear target DNA, a sec-
ond target was ligated onto the first, and integration into
the second target DNA was then monitored. Sliding of
the complex from one target to the other would result in
accumulation of integration product in the second target:
To allow integration in each target to be monitored, the
two targets were separated by digestion with a restriction
enzyme after the reaction was stopped. Such an approach
was used previously to demonstrate that the phage Mu B
protein (a sequence-nonspecific DNA-binding protein)
did not slide along DNA after binding [18].
Integrase-LTR complexes were formed by incubating
integrase and an LTR oligonucleotide at 37 C, and two
RESEARCH PAPER 1049
lo50 Current Biology 1995, Vol 5 No 9
target DNAs - X174 DNA (5.4 kb) and pMM105
DNA (3.1 kb), each linearized by digestion with PstI -
were added under various conditions. Firstly, the two tar-
get DNAs were added simultaneously, and then incubated
for 30 minutes at 37 C. Integration into both targets was
observed, as expected (Fig. 4a, lane 1). Reactions were
then carried out at 0 C - conditions in which ligase
remains active whereas integrase is inactive. Integrase-LTR
complexes were prebound to the two target DNAs for
20 seconds, immediately frozen in liquid nitrogen, and
then thawed and incubated on ice for one hour. After
this treatment, no integration product accumulated (Fig.
4, lane 2). When such a reaction mixture was subse-
quently warmed at 37 °C for 30 minutes, high levels of
integration products were obtained (Fig. 4, lane 3).
We also carried out mock ligation reactions in which
integrase-LTR complexes were prebound to one target
DNA and the second target was added 20 seconds later.
The mixtures were then quickly chilled by plunging in
liquid nitrogen, thawed on ice for one hour, and then
warmed to 37 C for 30 minutes. As expected, integra-
tion product was detected predominantly in the first target
added, whether it was the larger bX174 DNA target (Fig.
4, lane 4) or the smaller pMM105 target (Fig. 4, lane 7).
To ask whether integrase-LTR complexes could slide
along the target DNA, these latter integration reactions
were repeated with the addition of ligase and ATP during
the one hour incubation on ice. After this step, the bulk
target DNA and the integration product were both pre-
sent as high molecular weight forms, indicating that sub-
stantial ligation had taken place (Fig. 4a,b, lanes 5,8).
Cleavage of these ligated DNAs with PstI regenerated
the two linear DNA forms (Fig. 4a,b, lanes 6,9). Ligation
of the DNAs did not induce the accumulation of inte-
gration product in the second target DNA added, indi-
cating that substantial sliding along target DNA did not
take place during the one hour incubation on ice or the
time between warming of the reaction mixtures at 37 °C
and the completion of strand transfer. Note that previous
work determined that the lac repressor of Escherichia coli
can 'scan' about 103 base pairs per second by sliding [19];
thus, sufficient time should have elapsed in our integra-
tion reactions for sliding from one target DNA to the
other prior to strand transfer. Our data therefore indicate
that, under these conditions, target DNA capture
involves irreversible binding to target DNA without sub-
sequent sliding over long distances (consistent with the
pathway illustrated in Fig. 1c).
A fusion protein of integrase and a sequence-specific
DNA-binding domain as a probe of target site capture
The conclusions reached in the preceding section were
challenged by a second experimental approach, using a
fusion of HIV-1 integrase (IN) to the DNA-binding
domain of X repressor (XR). This fusion protein (XR-IN)
was shown previously to direct selective integration into
Fig. 4. Assay of sliding on target DNA
by bound integrase-LTR complexes.
(a) Autoradiogram revealing integration
product. (b) Bulk DNA in the same
electrophoresis gel, visualized by stain-
ing with ethidium bromide. For all reac-
tions, integrase was preincubated with
an end-labeled oligonucleotide for
5 min at 37 C prior to addition of target
DNA. Lane 1: integration products gen-
erated by adding two linear DNA targets
(+X+7-+ 174 and pMM105) simultane-
ously. Lane 2: integration products gen-
erated in similar reactions incubated for
1 h on ice. Lane 3: integration products
generated in reactions incubated on ice
for one hour, then warmed to 37 C for
30 min. Lane 4: addition of X174 DNA,
followed by addition of pMM105 DNA
20 sec later; reactions were chilled for
1 h, then warmed to 37 C for 30 min.
Lane 5: addition of cbX174 DNA, fol-
lowed by addition of pMM105 DNA
20 sec later; reactions were incubated
on ice for 1 h in the presence of ligase,
then warmed for 30 min at 37 C. Lane
6: similar to lane 5 except the ligated
integration products were separated by
cleavage with Pstl prior to elec-
trophoresis. Lanes 7-9 are identical to
lanes 4-6, except that pMM105 DNA
was added first.
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DNA targets containing recognition sites for X repressor
(operators). XR-IN was prebound to target DNA, and
the LTR oligonucleotide was added last to start the reac-
tion [8]. These conditions allowed the R domain to
bind and release many sequences before locating the
operators and binding tightly at that site. However,
under conditions in vitro in which the integrase part of
the fusion protein binds quickly and tightly to target
DNA, the XR domain may not be able to direct selective
integration efficiently because tight binding by the inte-
grase domain will prevent the XR domain from locating
the operators. The outcome of the competition between
the XR and integrase parts of the fusion, monitored by
selective integration, allows the mode of binding of the
integrase part to be assessed.
Initially, target DNA order-of-addition studies were per-
formed using R-IN in the presence of Mg2 + and
DMSO. XR-IN bound tightly to the first target DNA
added and, consistent with the results using wild-type
integrase, did not exchange onto a second target DNA
added just 20 seconds later (data not shown). To examine
in detail the integration sites selected under different
conditions, reactions were carried out in vitro and ana-
lyzed using the polymerase chain reaction (PCR) (Fig.
5a,b) [8,20,21]. Integration reactions were conducted
using an LTR oligonucleotide that was not end-labeled.
Products of integration reactions were deproteinized and
used as templates for PCR. PCR primers were selected
such that one primer was complementary to a target
DNA sequence, and the other was complementary to
the LTR oligonucleotide. The target primer was labeled
with 32p on the 5' end. PCR amplification of integra-
tion products generated a population of molecules that
were then denatured and analyzed on a DNA-sequenc-
ing-type gel. Each band on the gel corresponded to inte-
gration at a specific phosphodiester. The frequency of
integration at a particular site was reflected in the inten-
sity of the corresponding band on the final autoradi-
ogram, and the location of each integration site was
determined by co-electrophoresis with DNA sequencing
reactions. Integration was examined at the right operator
(OR) region of phage DNA, which contains three
binding sites for A repressor. PCR primers to either side
of OR were used to assay integration into each target
DNA strand (Fig. 5b, lanes 1-6).
Figure 5b presents the results of such an analysis of inte-
gration sites used by HIV integrase and KR-IN. Reac-
tions were carried out in the presence of MgC12 and
DMSO. Two different orders of addition were compared:
integrase or KR-IN was prebound to target DNA, and
then LTR oligonucleotide was added; or integrase or
XR-IN was preassembled with the LTR DNA, and the
complex subsequently incubated with target DNA.
For wild-type integrase assembled with the LTR
oligonucleotide in the presence of MgCI 2 and DMSO, a
band can be seen at most positions in the integration
product ladder, although the frequency of integration at
each phosphodiester varied over a broad range (Fig. 5b,
lanes 1,4). For unknown reasons, preincubating wild-
type integrase with the, target DNA under these condi-
tions prior to the addition of the LTR oligonucleotide
inhibited the reaction (data not shown).
In the case of reactions containing KR-IN, different
results were obtained depending on how the integration
complexes were assembled. When hR-IN was prebound
to target DNA and the LTR oligonucleotide added last,
selective integration was seen (Fig. 5b, lanes 3,6). Little
integration was seen into the regions containing the
repressor binding sites OR1 and OR2 , as expected if
KR-IN was bound at these sites. A similar 'footprint'
over this region can be seen in reactions containing wild-
type integrase and X repressor [8]. Integration took place
predominantly at a set of highly preferred sites adjacent to
the operators. Farther away from OR , integration events
were less frequent than in the products of reactions with
wild-type integrase. The hotspots for integration with
KR-IN lie on the same face of the DNA helix as the
repressor binding sites, consistent with a model in which
the KR-IN complex bound at OR captures the target
DNA by looping out the intervening sequences [8].
When KR-IN was preassembled with an LTR oligonu-
cleotide in the presence of Mg2 + and DMSO, however,
the operator DNA was only partially protected from
integration, and the strong enhancements seen when
KR-IN was prebound to target were greatly reduced in
intensity (Fig. 5b, lanes 2,5). Phosphodiesters far from
O R were used relatively efficiently by XR-IN following
assembly with the LTR DNA, as with wild-type inte-
grase. Thus, selective integration was inhibited by assem-
bling R-IN with LTR DNA. The XR-IN-LTR
complex apparently bound tightly to target DNA without
subsequent sliding (Fig. c), whereas KR-IN alone, when
incubated with target DNA, was capable of some form of
target DNA exploration (consistent with the pathways
shown in Fig. la,b).
Capture of target DNA by purified HIV-1 preintegration
complexes
The finding that complexes of HIV integrase, assembled
with LTR DNA in the presence of MgCl 2 and DMSO,
bind quickly and stably to target DNA raised the ques-
tion of whether the large nucleoprotein complexes that
carry out integration in vivo behave similarly. Such sub-
viral particles ('preintegration complexes') containing the
reverse-transcribed viral cDNA and associated proteins
can be obtained from freshly infected cells and are capa-
ble of integrating the endogenous viral cDNA into an
added target DNA in vitro [22-24].
To investigate target capture by preintegration com-
plexes, it was first necessary to determine the kinetics of
integration (Fig. 6a). Linear phage X174 target DNA
was added to complexes either in crude extracts or par-
tially purified, and samples were taken at time points
over 45 minutes. The samples were then deproteinized,
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separated by electrophoresis in a native agarose gel, blot-
ted to nylon membranes, and probed with labeled
sequences complementary to the HIV LTR. Integration
products were seen as bands with mobility equal to that
of the HIV DNA (9.7 kb) plus the (4X174 target DNA
(5.4 kb). Integration took place quickly, with a half-
maximal time of about three minutes for assays of both
cytoplasmic extracts and partially purified complexes
(Fig. 6a,b; data not shown). A titration of phage X174
target DNA established that 0.5 g was sufficient to
saturate the reaction (Fig. 6c).
To probe target-site capture, integration reactions were
carried out in which a target DNA was added to pre-
integration complexes as above, and then a second target
was added after 20 seconds. Reactions were subsequently
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Fig. 6. Characterization of integration reactions containing HIV-1 preintegration complexes. (a) Time course of integration. Time after
addition of the phage X174 target DNA is shown above the autoradiogram. The band corresponding to integration product (IP) is
marked. (b) Quantification of the kinetics of integration reactions containing preintegration complexes. Quantification was carried out
using a Molecular Dynamics Phosphorimager. Each point represents the average of two experiments. (c) Titration of phage X174
target DNA. The amount of X1 74 target DNA added is marked above the gel.
incubated for 30 minutes to allow integration product to
accumulate. Linear phage <X174 DNA was used as one
target, and sheared salmon sperm DNA as the other. Inte-
gration into the salmon sperm DNA yielded only a weak
background smear of integration products, as the frag-
ments of salmon sperm DNA are heterogeneous in size,
whereas integration into X174 DNA yielded a discrete
product band as described above.
For the case of preintegration complexes in cytoplasmic
extracts, the addition of 4X174 DNA first, followed by
salmon sperm DNA 20 seconds later, yielded integration
product as in reactions containing qX174 target DNA only
(Fig. 7a, lanes 1-3). When salmon sperm DNA was added
20 seconds before X174 DNA, integration products
were also seen into the X174 target DNA, indicating
that the preintegration complexes in cytoplasmic extracts
did not stably commit to the first target DNA added (Fig.
7a, lanes 4-6). A time course of integration carried out
in parallel confirmed that little integration took place
within the first 20 seconds (data not shown).
However, a different result was obtained with preintegra-
tion complexes partially purified by gel filtration. Inte-
gration into the 4X174 target DNA was seen only when
it was added first. No integration was detected when the
4X174 DNA was added 20 seconds after the salmon
sperm DNA (Fig. 7b, compare lanes 3,4). These results
are not due to fast integration into the first target added,
as a parallel time course showed that little integration
Fig. 7. Effects of order of target-DNA addition and of cytoplasmic extracts on integration reactions containing preintegration complexes.
(a) Results obtained using cytoplasmic extracts containing preintegration complexes. The order of addition of the two target DNAs -
phage X174 DNA (X) or salmon sperm (ss) DNA - is marked above the gel lanes. Times correspond to the interval between addi-
tion of the two targets. 'P' marks integration product, 'cDNA' marks the unintegrated HIV DNA. (b) Results obtained using
preintegration complexes partially purified by gel filtration. (c) Results obtained using partially purified preintegration complexes mixed
with cytoplasmic extracts from uninfected cells. Target DNAs were added 20 seconds apart. The methods for the analysis of target-
DNA capture described could not be used for reactions containing Mn2+ because the reaction proceeded too quickly (data not shown).
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product accumulated in the first 20 seconds (Fig. 7b,
lanes 1,2). Thus, preintegration complexes, partially
purified by gel filtration, bound quickly and tightly to
target DNA, but no such commitment was seen with
preintegration complexes in crude extracts.
To begin to examine whether host factors removed by
gel filtration were responsible for the difference in target
capture, the activity of preintegration complexes purified
by gel filtration was assessed in the presence of added
cytoplasmic extracts from uninfected cells. Integration
into the X174 target DNA was seen whether it was
added before or after the salmon sperm DNA challenger
(Fig. 7c, compare lanes 3,4). Addition of the lysis buffer
used to prepare the cytoplasmic extract did not block tar-
get commitment (data not shown). Evidently, compo-
nents of the host cell extract altered target DNA capture
so as to permit integration into the second DNA added.
Partially purified complexes therefore committed quickly
and tightly to the first target DNA added (consistent with
Fig. lb,c), whereas the presence of cytoplasmic extract
permitted exchange (consistent with Fig. la).
Discussion
The capture of target DNA by an integrase-LTR complex
prior to integration could, in principle, take place by any
of three mechanisms. The integrase-LTR complex might
bind and release candidate target DNA sequences several
times (Fig. la); the complex might bind to target DNA
and slide along it (Fig. lb); or the complex might inte-
grate at the initial site of binding (Fig. 1 c). The results we
have described show that complexes of purified integrase
assembled with LTR DNA in the presence of MgC12 and
DMSO bind quickly to target DNA, without dissocia-
tion prior to integration (consistent with the pathways
shown in Fig. lb,c). Further experiments established that
the target-bound complex does not slide far along the
DNA (consistent with the pathway shown in Fig. 1c).
We also investigated target capture using a fusion protein
composed of the HIV-1 integrase fused to the DNA-
binding domain of X repressor. In this case, the outcome
of the competition between the two DNA-binding
domains under different conditions provides insights into
the function of each. XR-IN preassembled with LTR
DNA failed to direct selective integration at XR-binding
sites in the presence of MgCl 2 and DMSO, although
selective integration was seen in other conditions. Evi-
dently, in the presence of MgC12 and DMSO, the inte-
grase part of the fusion binds tightly to target DNA
without subsequent sliding (consistent with Fig. 1 c),
thereby preventing the repressor domain from locating its
recognition site efficiently.
The results of target-commitment experiments using
preintegration complexes from HIV-infected cells were
different depending on whether or not a source of
host factors was present. Partially purified complexes
committed quickly and stably to the first target DNA
added (consistent with Fig. lb,c), whereas preintegration
complexes in crude cytoplasmic extracts did not display
fast template commitment (consistent with Fig. la). The
addition of a cytoplasmic extract to partially purified
complexes blocked quick commitment, consistent with
the idea that the mechanism of target-site selection may
be influenced by cellular factors in vivo.
DNA sliding
Previous studies have revealed that several sequence-
specific DNA-binding proteins probably locate their
recognition sites by first binding to nonspecific DNA and
then diffusing laterally (sliding) - the E. coli lac repres-
sor, the restriction enzyme EcoRl and X Cro protein
have all been reported to use this mechanism [19,25,26].
However, the phage Mu B protein, a recombination
enzyme cofactor, does not slide along DNA detectably
after binding [18]. Mu B, together with Mu A trans-
posase, catalyzes transposition of Mu DNA. Mu B binds
to target DNA sites in a sequence-nonspecific fashion
and, once bound, stimulates DNA strand transfer by Mu
A. In a ligation assay such as that presented in Figure 4,
Mu B did not slide detectably along DNA after binding.
The finding that the Mu and HIV recombination systems
can bind DNA rapidly without subsequent sliding sug-
gests that such binding may be a general property of
these enzymes in vitro.
Although integrase-LTR complexes do not slide for long
distances in the presence of Mg2+, the detailed pattern of
integration sites used indicates that the complex may slide
within a limited region. In the PCR analysis of integration
sites shown in Figure 5, as in previous studies [27-29], dif-
ferent sites are used as integration targets with varying effi-
ciencies. It seems unlikely that such variation is due to
differences in the accessibility of sites in the,naked target
DNAs. Perhaps the integrase-LTR complex explores a
few nearby base pairs in the course of target DNA capture,
with the observed hotspots representing sequences that are
particularly favorable for binding or catalysis. Alternatively,
complexes bound to unfavorable sites may be quickly
released and rebound elsewhere. In our experiments, such
exchange would have to take place prior to the addition of
competitor DNA (within 20 seconds).
An integrase-k repressor fusion protein as a probe of target
DNA capture
The fusion protein composed of the DNA-binding
domain of X repressor and the HIV integrase (XR-IN)
provides a novel tool for studying the mechanism of
target-DNA capture. For a sequence-specific DNA-
binding protein to locate its recognition sequence, it
must either bind and release many nonspecific DNA
sequences or slide along nonspecific DNA once bound.
Such scanning of DNA sites is necessary in order to
locate the specific recognition sequence. If the protein is
restricted in its exploration of DNA, then specific bind-
ing may not take place. Thus, the competition between
the integrase and XR parts of XR-IN, as revealed by
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occupancy of the repressor site, serves as a reporter for
the mode of binding by the integrase domain.
We found that the efficiency of selective integration was
influenced by the reaction conditions employed. XR-
IN-LTR complexes assembled in the presence of Mg2 +
and DMSO displayed little selective integration, as
expected from the finding that complexes of wild-type
integrase bound to LTR DNA under these conditions
commit quickly to target DNA without sliding. How-
ever, under these conditions, prebinding of XR-IN to
target DNA prior to adding the LTR oligonucleotide did
permit selective integration. Perhaps prebinding of the
LTR oligonucleotide alters the behavior of the target-
DNA binding site, converting it from relatively low to
relatively high affinity.
Implications for integration in vivo
Our findings indicate that target DNA capture is differ-
ent in reactions containing partially purified preintegra-
tion complexes than in reactions containing complexes
and cellular factors. The mechanism of action of the cel-
lular factors is unknown, as is the biological significance
of this observation. One model for the mechanism
invokes the effects of host proteins bound to target DNA.
It has been shown previously that the DNA-binding
domain of the yeast GAL4 protein binds its recognition
site 10-fold less tightly in nucleosomal DNA than in
naked DNA [30]. Perhaps the presence of host DNA-
binding proteins bound to target DNA destabilizes the
initial association of preintegration complexes with the
target and thereby permits exchange between targets.
The mechanism of target-site capture is a critical deter-
mrinant of whether fusion proteins, such as XR-IN, that
contain integrase linked to sequence-specific DNA-bind-
ing domains will direct selective integration in viva, an
issue of interest in developing gene therapy methods [31].
It seems most likely that conditions in vivo resemble those
seen with preintegration complexes in the presence of
host factors, in which stable target-site commitment is
not seen (Fig. la). If so, integrase fusions may be able to
locate specific sites and direct selective integration in vivo.
Materials and methods
DNA manipulations
Plasmid A (Fig. 3) was p5XCRE - pGEM with five CRE
sites cloned into the polylinker site (a gift from M. Montminy
and P. Brindle). Plasmid B was pBW18, a derivative of
pUC19 in which the amp gene has been replaced with a SupF
selectable marker. Plasmid pMM105, used as target in Figure
4, was constructed by inserting a synthetic oligonucleotide
matching in sequence LAV bases 9605-9706 into pBSIISK+
(Stratagene). This plasmid was chosen as target because it is
smaller than phage X174 DNA and, like <>X174 DNA, it
contains a single PstI site.
Integration assays
HIV-1 integrase was purified essentially as described [15];
XR-IN was purified as described [8]. Integration reactions in
the presence of 5 mM MnCl 2 were carried out as described
[12]. Reactions carried out in the presence of 5 mM MgCl2
contained, in addition, 25 mM Hepes pH 7.5, 10 mM BME,
10 % glycerol, 0.1 mg ml-1 BSA, 13 ng I-1 HIV-1 integrase,
0.1 ng pl-l LTR oligonucleotide (FB79 [8]) 20 % DMSO and
10 U 1l RNAse T1. Plasmid target DNA was added at a con-
centration of 50 ng u-1. Reactions were stopped by addition of
one-fourth volume 100 mM EDTA, 1 % SDS, in gel-loading
buffer. Reaction products were separated by electrophoresis on
1 % agarose gels in TAE containing ethidium bromide. Integra-
tion products were visualized by autoradiography after drying
the gels. PCR-based assays of integration site selection in phage
K DNA were carried out as described [8].
Purification and assay of preintegration complexes
Preintegration complexes were purified and analyzed as
described in [24] and modified in [32]. In some cases, extracts
containing preintegration complexes were further purified by
gel filtration. Spin columns were prepared using about 2 ml
BSA-coated Sephacryl S400 in Buffer K. Cytoplasmic extract
(200 pl) in Buffer K plus 0.5 % Triton was loaded per column
and columns were centrifuged for 3 min at 1000 rpm in a Sor-
val RT6000B centrifuge. This procedure removed about 95 %
of the total protein from the extracts containing preintegration
complexes as measured by the BCA Protein Assay (Pierce).
Integration assays were performed as described by adding
0.5 ig target DNA to preintegration complexes in Buffer K
followed by incubation at 37 C. Integration products were
deproteinized, separated on agarose gels, and visualized by
Southern blotting as described [24,32]. Cytoplasmic extracts
from uninfected cells were prepared exactly as were extracts
from infected cells.
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